Next Article in Journal
CT-Assessed Body Composition as Predictor of Post-Operative Complications in Lung Cancer Patients
Next Article in Special Issue
Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”
Previous Article in Journal
Targeting Pathways Implicated in Cholesterol Metabolism for Novel Cancer Therapy
Previous Article in Special Issue
Single-Cell Heterogeneity of Epigenetic Factor Regulation Deciphers Alteration of RNA Metabolism During Proliferative SHH-Medulloblastoma
 
 
Comment

Article Versions Notes

Cancers 2026, 18(3), 429; https://doi.org/10.3390/cancers18030429
Action Date Notes Link
article html file updated 29 January 2026 08:00 CET Original file https://www.mdpi.com/2072-6694/18/3/429/html
article pdf uploaded. 29 January 2026 07:58 CET Version of Record https://www.mdpi.com/2072-6694/18/3/429/pdf
article xml uploaded. 29 January 2026 07:58 CET Update https://www.mdpi.com/2072-6694/18/3/429/xml
article xml file uploaded 29 January 2026 07:58 CET Original file -
Back to TopTop